RecruitingNCT06860438

Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis

Can Perfusion Index Indicate the Need of Vasopressor in ICU Patients with Sepsis and Septic Shock, Prospective Observational Study


Sponsor

Ain Shams University

Enrollment

40 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

In this thesis we will use the current state of knowledge that PI can provide a reliable information about the state of peripheral microcirculation during the state of sepsis and septic shock in ICU patients and that can interfere with the timing of starting vasopressor treatment in sepsis and septic shock


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Vasoconstrictor Agents for people with perfusion index, sepsis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVasoconstrictor Agents

vasopressor agents will be started in patients with sepsis who will not improved using the resuscitation fluids


Locations(1)

faculty of medicine Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06860438


Related Trials